High -level talents promote the leap -forward development of Yiling Pharmaceutical

Great Wall Network · Jiyun Client News (Reporter ’s group Zhang Jianxun) On June 5th, Li Mengnan, a young man in Hainan in Shijiazhuang, remembered a scene two years ago and still felt very warm.

Two years ago, Li Mengnan, who was engaged in study and scientific research at the Max Planck Institute in Germany, received a "healthy package" from the staff of the embassy. As well as Lianhua Qing Plague capsule, he felt that Lianhua Qingjuan capsule effect was good, and he was curious about its production enterprise Yiling Pharmaceutical. After that, he continued to pay attention to the research and development of Yiling Pharmaceutical.

In June 2021, Li Mengnan successfully received a doctorate degree and made an important decision -back to China, joined Yiling Pharmaceutical, and took root in Hebei.

At present, Li Mengnan, who is already the director of R & D of the Ridge Pharmaceutical Anti -Aging Platform: "After coming to Yiling Pharmaceutical, I found that there were more than 50 million yuan to buy advanced research instruments. Some were even better than what I used in Germany. Pharmaceutical companies that pay attention to research and development innovation make me feel excited. "

Li Mengnan (first from right) is studying the experimental data with colleagues. Great Wall Network · Jiyun Client reporter Yanyu Group Photo

Similarly, as one of the high -level talents introduced by Yiling Pharmaceuticals, Qi Hui, who came out of Zhengding County and asked for many years outside, got a doctorate degree in Germany, and for a while, she said goodbye to her husband and returned to China to join Yiling Pharmaceuticals with Lingling Pharmaceuticals. Industry has become the core member of the anti -aging team.

"In terms of drug research and development, our team can open up a platform -related platform to combine traditional Chinese medicine theoretical innovation and modern science and technology. These R & D concepts attract me very much. As a researcher, I can give full play to the expertise here. Strong sense of belonging and accomplishment. "Qi Hui said.

Compared to Li Mengnan and Qi Hui, Hou Yunlong in Harbin joined Yiling Pharmaceuticals earlier. In 2018, Shijiazhuang City introduced various types of talent introduction and training policies in order to achieve the goal of building a 100 billion -level industrial cluster. In October 2018, Hou Yunlong after returning from Germany, as a doctor of returnees, a special expert in the province, and excellent overseas talents, was introduced to Yiling Pharmaceutical's work and served as the vice president of Yi Ling Pharmaceutical Center. He is a master's degree instructor at the School of Medicine of Hebei Medical University and a doctoral supervisor at Hebei University of Traditional Chinese Medicine.

Hou Yunlong was responsible for building three drug research and development platforms: cardiovascular drugs, aging research and anti -aging drugs, and respiratory disease drugs. It established and cultivated the domestic first -class technology -level R & D team, which greatly promoted the progress of new drug research and development. At present, Hou Yunlong is guiding three doctoral graduate students and 3 master's degree students to conduct a number of topic studies.

"When I came to Yiling, in addition to daily work, I also devoted himself to the development of innovative drugs and obtained the clinical approval of drugs. This is the greatest satisfaction for a scientific researcher. The platform provided by the company allows me and me and me The team combines scientific research ideas with products to realize her dream step by step, "Hou Yunlong said.

Xu Weidong, executive deputy director of the Evil Pharmaceutical Human Management Center, introduced the introduction of talents. Photo by Zhang Jianxun, a reporter from Great Wall Network · Jiyun Client

The innovation of the product not only requires capital investment, "people" is the key to deciding whether success or not. "We have adopted one person and one strategy for the introduction of high -end talents. In response to the characteristics of different people, we have personalized the strategy of introducing talents. Through citation and wisdom, and the training and empowerment of talents, we will ensure that our team will be the company's future for the company's future. The development can play a greater role. "Xu Weidong, executive deputy director of Yiling Pharmaceutical Human Manpower Center.

The reporter learned that Yiling Pharmaceuticals has created the "advanced path" of talents that develops the rapid development of enterprises through internal education and outside: Internal and development of various types of innovation platforms, and continue to carry out the construction of backup talents. The introduction of various talents such as middle and high -end pharmaceutical research and development, technology and management. At present, the company has gathered a large number of elites of scientific research, production, and management, including foreign experts, returning experts, doctoral degrees, master's degree and other senior talents. The graduate degree or above of R & D personnel accounts for 80%.

Under the support of strong talent strategy, Yiling Pharmaceutical has developed and launched 13 new patent drugs, and has undertaken and completed the National "973 Plan", the National "863 Plan", the National "Eleventh Five -Year Plan" support, the country's "Ten Ten" The second and fifth "major new drug creation and national key research and development plan and other major national projects were more than 40 national projects. They won 6 national awards and won more than 700 domestic and foreign patents.

- END -